$0.09
(Market cap
$32,120 Mln
Revenue (TTM)
$9,517 Mln
P/E Ratio
12.7
P/B Ratio
9.8
Div. Yield
2.8 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$1,324 Mln
-
ROE
0.6 %
-
ROCE
22 %
-
Industry P/E
37.32
-
EV/EBITDA
9.6
-
Debt to Equity
2.9
-
Book Value
$--
-
EPS
$6.1
-
Face value
--
-
Shares outstanding
413,223,602
10 Years Aggregate
CFO
$15,538.00 Mln
EBITDA
$21,920.00 Mln
Net Profit
$13,668.00 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Zoetis Inc. Class A (ZTS)
| -38.7 | -0.1 | -0.6 | -50.6 | -26.0 | -17.7 | 4.2 |
|
BSE Sensex
| -9.1 | -1.5 | 2.9 | -3.6 | 5.9 | 6.0 | 10.5 |
|
S&P 100
| 9.7 | 4.3 | 0.5 | 18.7 | 21.5 | 12.7 | 14.7 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Zoetis Inc. Class A (ZTS)
| -22.8 | -17.3 | 34.7 | -39.9 | 48.3 | 25.8 | 55.7 |
|
S&P 100
| 18.7 | 29.0 | 30.8 | -22.1 | 27.6 | 19.3 | 29.5 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Zoetis Inc. Class A (ZTS)
|
77.2 | 32,119.9 | 9,517.0 | 2,616.0 | 27.1 | 80.8 | 12.7 | 9.8 |
| 260.0 | 462,684.3 | 64,386.0 | 6,314.0 | 20.7 | -- | 75.2 | 50.5 | |
| 433.8 | 233,780.1 | 38,125.0 | 8,743.0 | 25.0 | 85.9 | 26.9 | 20.2 | |
| 66.9 | 136,882.3 | 49,187.0 | 9,282.0 | 27.7 | 45.5 | 14.8 | 6.0 | |
| 1,176.7 | 1,109,683.0 | 79,665.8 | 26,709.5 | 31.2 | 88.4 | 42.9 | 33.7 | |
| 148.5 | 180,636.7 | 30,456.0 | -3,240.0 | 29.7 | -18.8 | 17.7 | 15.6 | |
| 267.9 | 644,334.6 | 97,929.0 | 21,037.0 | 26.5 | 25.3 | 31.8 | 7.8 | |
| 149.2 | 367,583.9 | 66,400.0 | 3,173.0 | 10.9 | 6.7 | 122.1 | 9.0 | |
| 161.5 | 296,967.7 | 55,634.9 | 12,759.1 | 30.4 | 29.1 | 23.6 | 7.3 | |
| 28.6 | 158,393.9 | 63,696.0 | 4,335.0 | 10.8 | 5 | 36.6 | 1.9 |
Shareholding Pattern
View DetailsAbout Zoetis Inc. Class A (ZTS)
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the... United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey. Read more
-
CEO & Director
Ms. Kristin C. Peck
-
CEO & Director
Ms. Kristin C. Peck
-
Headquarters
Parsippany, NJ
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Zoetis Inc. Class A (ZTS)
What is the current share price of Zoetis Inc Class A (ZTS) Today?
The share price of Zoetis Inc Class A (ZTS) is $77.19 (NYSE) as of 01-Sep-2026 11:44 EDT. Zoetis Inc Class A (ZTS) has given a return of -26% in the last 3 years.
What is the current PB & PE ratio of Zoetis Inc Class A (ZTS)?
The P/E ratio of Zoetis Inc Class A (ZTS) is 12.68 times as on 21-Aug-2026, a 66 discount to its peers’ median range of 37.32 times.
The P/B ratio of Zoetis Inc Class A (ZTS) is 9.85 times as on 21-Aug-2026, a 27 premium to its peers’ median range of 7.75 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
20.65 |
16.57 |
2024 |
29.56 |
15.41 |
2023 |
38.74 |
18.17 |
2022 |
32.36 |
15.53 |
2021 |
56.98 |
25.55 |
What is the 52 Week High and Low of Zoetis Inc Class A (ZTS)?
The 52-week high and low of Zoetis Inc Class A (ZTS) are Rs 155.38 and Rs 71.00 as of 01-Sep-2026.
What is the market cap of Zoetis Inc Class A (ZTS)?
Zoetis Inc Class A (ZTS) has a market capitalisation of $ 32,120 Mln as on 21-Aug-2026. As per SEBI classification, it is a Large Cap company.
Should I invest in Zoetis Inc Class A (ZTS)?
Before investing in Zoetis Inc Class A (ZTS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.